# Alamar Biosciences IPO (ALMR): price, date and first-day trading

> Alamar Biosciences (ALMR) priced its IPO at $17.00 a share and has traded on Nasdaq since Apr 17, 2026.

Canonical: https://massive.com/quote/almr/ipo
Data as of: 2026-11-19T00:30:03.254Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## ALMR price

| Figure | Value |
| --- | --- |
| Price | $30.51 |
| Change from the IPO price | +79.47% |
| Change today | -0.42% |

## How ALMR did against the market

ALMR against the market, from its first trade at 12:30 ET to the last trade of the session.

| Measure | Value |
| --- | --- |
| ALMR from its first trade | -0.31% |
| Against the market (QQQ) | -0.2 pts |

## The IPO scoreboard

ALMR against other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.

| IPO | Raised | First trade | Day 1 close | Day 5 | Day 30 |
| --- | --- | --- | --- | --- | --- |
| Alamar Biosciences | $191.25M | +32.94% | +32.53% | +42.94% | +20.35% |
| Figma '25 | $1.22B | +157.58% | +252.42% | +173.64% | +69.64% |
| Circle '25 | $1.05B | +122.58% | +168.45% | +278.18% | +622.98% |
| Reddit '24 | $748M | +38.24% | +47.97% | +69.90% | +40.32% |
| Arm '23 | $5.23B | +10.00% | +23.76% | +3.63% | -3.06% |
| Klarna '25 | $1.37B | +30.00% | +16.14% | +13.73% | -7.33% |
| CoreWeave '25 | $1.5B | -2.50% | +0.02% | +34.32% | +28.42% |

## The offering

| Term | Value |
| --- | --- |
| Expected price range | $15 to $17 |
| IPO price | $17.00 |
| Shares offered | 11.25M |
| Money raised | $191.25M |
| Listing date | Apr 17, 2026 |
| Exchange | Nasdaq |
| Security | Ordinary Shares |

## Where ALMR ranks

The company's market cap against the largest US-listed companies.

| Company | Market cap |
| --- | --- |
| AAPL | $5.12T |
| MSFT | $3.77T |
| NVDA | $3.65T |
| GOOGL | $3.47T |
| AMZN | $2.9T |
| TSM | $1.88T |
| AVGO | $1.69T |
| META | $1.58T |
| TSLA | $1.52T |
| BRK.B | $1.22T |
| ALMR | $2.12B |

## Insider buying and selling after the IPO

From Sep 3, 2026 to Nov 19, 2026, 7 ALMR insiders reported open-market sales of $47.5M across 48 filings; no open-market purchases were filed.

- Qiming Venture Partners VI, L.P., 10% owner: sold $3.1M, filed Oct 19, 2026
- Qiming Venture Partners VIII-HC, L.P., 10% owner: sold $3.0M, filed Oct 23, 2026
- Qiming GP VIII, LLC, 10% owner: sold $2.8M, filed Oct 23, 2026
- Qiming Managing Directors Fund VI, L.P., 10% owner: sold $2.7M, filed Oct 27, 2026
- Qiming Managing Directors Fund VI, L.P., 10% owner: sold $2.7M, filed Oct 21, 2026

Sales made in the offering itself are left out.

[Who traded and when](https://massive.com/quote/almr/insider-trading.md)

## ALMR news

- [Alamar (ALMR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates](https://www.zacks.com/stock/news/3022269/alamar-almr-q3-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-3022269) · Zacks Investment Research · Nov 3, 2026
- [UPDATE -- Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study](https://www.globenewswire.com/news-release/2026/11/03/3393856/0/en/update-alamar-biosciences-and-nightingale-health-to-lead-uk-biobank-80-000-sample-neurodegenerative-disease-study.html) · GlobeNewswire Inc. · Nov 2, 2026
- [Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment](https://www.globenewswire.com/news-release/2026/09/24/3368813/0/en/lancet-neurology-study-using-alamar-biosciences-technology-reveals-divergent-biological-responses-to-alzheimer-s-treatment.html) · GlobeNewswire Inc. · Sep 24, 2026
- [Alamar Biosciences 联合多所顶尖研究型大学推出全国性研究计划，推进神经退行性疾病血液生物标志物相关研究](https://www.globenewswire.com/news-release/2026/07/13/3326384/0/zh-hans/Alamar-Biosciences-%E8%81%94%E5%90%88%E5%A4%9A%E6%89%80%E9%A1%B6%E5%B0%96%E7%A0%94%E7%A9%B6%E5%9E%8B%E5%A4%A7%E5%AD%A6%E6%8E%A8%E5%87%BA%E5%85%A8%E5%9B%BD%E6%80%A7%E7%A0%94%E7%A9%B6%E8%AE%A1%E5%88%92-%E6%8E%A8%E8%BF%9B%E7%A5%9E%E7%BB%8F%E9%80%80%E8%A1%8C%E6%80%A7%E7%96%BE%E7%97%85%E8%A1%80%E6%B6%B2%E7%94%9F%E7%89%A9%E6%A0%87%E5%BF%97%E7%89%A9%E7%9B%B8%E5%85%B3%E7%A0%94%E7%A9%B6.html) · GlobeNewswire Inc. · Jul 13, 2026
- [Alamar Biosciences 與多間頂尖研究大學合作啟動全國計劃，旨在推動神經退行性疾病相關的血漿生物標記研究](https://www.globenewswire.com/news-release/2026/07/13/3326384/0/zh-hant/Alamar-Biosciences-%E8%88%87%E5%A4%9A%E9%96%93%E9%A0%82%E5%B0%96%E7%A0%94%E7%A9%B6%E5%A4%A7%E5%AD%B8%E5%90%88%E4%BD%9C%E5%95%9F%E5%8B%95%E5%85%A8%E5%9C%8B%E8%A8%88%E5%8A%83-%E6%97%A8%E5%9C%A8%E6%8E%A8%E5%8B%95%E7%A5%9E%E7%B6%93%E9%80%80%E8%A1%8C%E6%80%A7%E7%96%BE%E7%97%85%E7%9B%B8%E9%97%9C%E7%9A%84%E8%A1%80%E6%BC%BF%E7%94%9F%E7%89%A9%E6%A8%99%E8%A8%98%E7%A0%94%E7%A9%B6.html) · GlobeNewswire Inc. · Jul 13, 2026
- [Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases](https://www.globenewswire.com/news-release/2026/07/13/3325908/0/en/Alamar-Biosciences-Partners-with-Leading-Research-Universities-to-Launch-National-Initiative-Advancing-Blood-Based-Biomarkers-for-Neurodegenerative-Diseases.html) · GlobeNewswire Inc. · Jul 13, 2026

## Filings and the company

Material events that Alamar Biosciences has disclosed to the SEC on Form 8-K.

- Nov 3, 2026 · Executive officer departure ([filing](https://www.sec.gov/Archives/edgar/data/2104204/0001193125-26-445353.txt))
- Sep 1, 2026 · Director appointment ([filing](https://www.sec.gov/Archives/edgar/data/2104204/0001193125-26-378360.txt))
- Jul 15, 2026 · Director departure ([filing](https://www.sec.gov/Archives/edgar/data/2104204/0001193125-26-304736.txt))
- Apr 20, 2026 · Public offering ([filing](https://www.sec.gov/Archives/edgar/data/2104204/0001193125-26-163921.txt))

## FAQ

### What was the Alamar Biosciences IPO price?

$17.00 a share.

### When did Alamar Biosciences go public?

Alamar Biosciences listed on Nasdaq on Apr 17, 2026 under the ticker ALMR.

### How much did the Alamar Biosciences IPO raise?

$191.25M, before any underwriters' option.

### How did Alamar Biosciences open on its first day?

ALMR first traded at $22.60, +32.94% from the IPO price of $17.00.

### How did ALMR close on its first day?

Its last regular-session trade was $22.53, +32.53% from the IPO price of $17.00.

### What was the ALMR first-day trading range?

$21.50 to $24.50 in the regular session.

### How many ALMR shares traded on the first day?

4.76M shares in the regular session.

### How many shares did Alamar Biosciences sell in its IPO?

11.25M shares.

### How did ALMR do against the market on its first day?

ALMR fell 0.3% from its first trade to the last trade of the session. That is 0.2 points worse than the market (QQQ, the Nasdaq-100 ETF).

### What exchange is ALMR listed on?

Alamar Biosciences lists on Nasdaq under the ticker ALMR.

## Live data

The IPO record and the price come from the Massive API.

- `GET https://api.massive.com/vX/reference/ipos?ticker=ALMR`
- `GET https://api.massive.com/v3/snapshot?ticker.any_of=ALMR`
- `GET https://api.massive.com/v2/aggs/ticker/ALMR/range/5/minute/{date}/{date}`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Markets overview](https://massive.com/quote/index.md)
- [Insider trading](https://massive.com/quote/insider-trading.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
